Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALLOB in Rescue Interbody Lumbar Fusion (Phase IIa Pilot)
2014-002416-16Phase 2Completed
- Sponsor
- BioSenic
- Start
- Jul 2014
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of allogeneic osteoblastic cells in post-laminectomy syndrome (PLS) and Pseudarthrosis Following Spinal Fusion, sponsored by BioSenic. Primary endpoints: Primary safety and efficacy over 12 months and Safety criteria. Started Jul 2014; status: completed.
02
Drugs
allogeneic osteoblastic cells
03
Conditions
post-laminectomy syndrome (PLS)Pseudarthrosis Following Spinal Fusion
Beyond the preview
Go deeper on 2014-002416-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002416-16.